House Oversight Democrats held a field hearing on May 12 in West Palm Beach, Florida, where Epstein survivors delivered emotional testimony detailing abuses and criticizing delays in file releases by the Department of Justice, signaling a "new phase" in the congressional probe. This partisan event, led by Ranking Member Robert Garcia, intensified calls for full committee hearings, subpoenas, and high-profile witnesses amid ongoing scrutiny of Epstein associates. Earlier 2026 developments included questioning of Commerce Secretary nominee Howard Lutnick on his Epstein ties and prior appearances by Attorney General Pam Bondi, though no resolutions on major figures. Traders weigh the June 30 deadline for qualifying testimony before Congress or committees, with potential votes or nominations driving near-term catalysts in this closely contested landscape.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour$61,053 Vol.
30 juin 2026
Elon Musk
35%
Donald Trump
9%
L’ex-prince Andrew
11%
Lord Peter Mandelson
6%
Ghislaine Maxwell
5%
$61,053 Vol.
Elon Musk
$1,090 Vol.
35%
Donald Trump
$638 Vol.
9%
L’ex-prince Andrew
$1,150 Vol.
11%
Lord Peter Mandelson
$2,490 Vol.
6%
Ghislaine Maxwell
$5,775 Vol.
5%
This market will resolve to "Yes" if the listed individual provides testimony about Jeffrey Epstein before either chamber of the United States Congress (House of Representatives or Senate), or any of their official committees or subcommittees, by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Qualifying testimony may be either live or recorded, in-person or remote, and closed or open to the public.
A primary focus of the testimony must be information related to Jeffrey Epstein, including but not limited to the listed individuals’ relationship with Epstein, their appearance in Epstein-related files released by the federal government, their involvement in previous Epstein investigations or criminal proceedings, or their general knowledge of Epstein and his life. Limited references to Epstein in an otherwise unrelated congressional testimony will not qualify.
The resolution source for this market will be a consensus of credible reporting.House Oversight Democrats held a field hearing on May 12 in West Palm Beach, Florida, where Epstein survivors delivered emotional testimony detailing abuses and criticizing delays in file releases by the Department of Justice, signaling a "new phase" in the congressional probe. This partisan event, led by Ranking Member Robert Garcia, intensified calls for full committee hearings, subpoenas, and high-profile witnesses amid ongoing scrutiny of Epstein associates. Earlier 2026 developments included questioning of Commerce Secretary nominee Howard Lutnick on his Epstein ties and prior appearances by Attorney General Pam Bondi, though no resolutions on major figures. Traders weigh the June 30 deadline for qualifying testimony before Congress or committees, with potential votes or nominations driving near-term catalysts in this closely contested landscape.
This market will resolve to "Yes" if the listed individual provides testimony about Jeffrey Epstein before either chamber of the United States Congress (House of Representatives or Senate), or any of their official committees or subcommittees, by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Qualifying testimony may be either live or recorded, in-person or remote, and closed or open to the public.
A primary focus of the testimony must be information related to Jeffrey Epstein, including but not limited to the listed individuals’ relationship with Epstein, their appearance in Epstein-related files released by the federal government, their involvement in previous Epstein investigations or criminal proceedings, or their general knowledge of Epstein and his life. Limited references to Epstein in an otherwise unrelated congressional testimony will not qualify.
The resolution source for this market will be a consensus of credible reporting.
Qualifying testimony may be either live or recorded, in-person or remote, and closed or open to the public.
A primary focus of the testimony must be information related to Jeffrey Epstein, including but not limited to the listed individuals’ relationship with Epstein, their appearance in Epstein-related files released by the federal government, their involvement in previous Epstein investigations or criminal proceedings, or their general knowledge of Epstein and his life. Limited references to Epstein in an otherwise unrelated congressional testimony will not qualify.
The resolution source for this market will be a consensus of credible reporting.
Marché ouvert : Feb 2, 2026, 2:59 PM ET
Volume
$61,053Date de fin
30 juin 2026Marché ouvert
Feb 2, 2026, 2:59 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the listed individual provides testimony about Jeffrey Epstein before either chamber of the United States Congress (House of Representatives or Senate), or any of their official committees or subcommittees, by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Qualifying testimony may be either live or recorded, in-person or remote, and closed or open to the public.
A primary focus of the testimony must be information related to Jeffrey Epstein, including but not limited to the listed individuals’ relationship with Epstein, their appearance in Epstein-related files released by the federal government, their involvement in previous Epstein investigations or criminal proceedings, or their general knowledge of Epstein and his life. Limited references to Epstein in an otherwise unrelated congressional testimony will not qualify.
The resolution source for this market will be a consensus of credible reporting.House Oversight Democrats held a field hearing on May 12 in West Palm Beach, Florida, where Epstein survivors delivered emotional testimony detailing abuses and criticizing delays in file releases by the Department of Justice, signaling a "new phase" in the congressional probe. This partisan event, led by Ranking Member Robert Garcia, intensified calls for full committee hearings, subpoenas, and high-profile witnesses amid ongoing scrutiny of Epstein associates. Earlier 2026 developments included questioning of Commerce Secretary nominee Howard Lutnick on his Epstein ties and prior appearances by Attorney General Pam Bondi, though no resolutions on major figures. Traders weigh the June 30 deadline for qualifying testimony before Congress or committees, with potential votes or nominations driving near-term catalysts in this closely contested landscape.
This market will resolve to "Yes" if the listed individual provides testimony about Jeffrey Epstein before either chamber of the United States Congress (House of Representatives or Senate), or any of their official committees or subcommittees, by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Qualifying testimony may be either live or recorded, in-person or remote, and closed or open to the public.
A primary focus of the testimony must be information related to Jeffrey Epstein, including but not limited to the listed individuals’ relationship with Epstein, their appearance in Epstein-related files released by the federal government, their involvement in previous Epstein investigations or criminal proceedings, or their general knowledge of Epstein and his life. Limited references to Epstein in an otherwise unrelated congressional testimony will not qualify.
The resolution source for this market will be a consensus of credible reporting.
Qualifying testimony may be either live or recorded, in-person or remote, and closed or open to the public.
A primary focus of the testimony must be information related to Jeffrey Epstein, including but not limited to the listed individuals’ relationship with Epstein, their appearance in Epstein-related files released by the federal government, their involvement in previous Epstein investigations or criminal proceedings, or their general knowledge of Epstein and his life. Limited references to Epstein in an otherwise unrelated congressional testimony will not qualify.
The resolution source for this market will be a consensus of credible reporting.
Volume
$61,053Date de fin
30 juin 2026Marché ouvert
Feb 2, 2026, 2:59 PM ETResolver
0x65070BE91...House Oversight Democrats held a field hearing on May 12 in West Palm Beach, Florida, where Epstein survivors delivered emotional testimony detailing abuses and criticizing delays in file releases by the Department of Justice, signaling a "new phase" in the congressional probe. This partisan event, led by Ranking Member Robert Garcia, intensified calls for full committee hearings, subpoenas, and high-profile witnesses amid ongoing scrutiny of Epstein associates. Earlier 2026 developments included questioning of Commerce Secretary nominee Howard Lutnick on his Epstein ties and prior appearances by Attorney General Pam Bondi, though no resolutions on major figures. Traders weigh the June 30 deadline for qualifying testimony before Congress or committees, with potential votes or nominations driving near-term catalysts in this closely contested landscape.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes